Itching during pregnancy is remarkably common, affecting roughly one in three women over the course of gestation, with the third trimester being the peak period.1Dermatology Research and Practice. Prevalence and Relevance of Pruritus in Pregnancy Most of the time, mild itchiness is a nuisance driven by skin stretching and hormonal shifts. In a small but important minority, though, intense itching signals a liver condition called intrahepatic cholestasis of pregnancy that can affect the baby. Understanding which kind of itching you’re dealing with, and what to do about each, is the practical challenge.
Why Pregnancy Makes Your Skin Itch
The most straightforward explanation is mechanical. As the abdomen expands, the skin stretches and dries, especially in the third trimester. The stretching alone can trigger mild, diffuse itching across the belly, breasts, and thighs without any rash or visible skin change. Hormonal shifts amplify the problem. Rising estrogen and progesterone alter bile flow, change how the skin retains moisture, and modulate the immune system in ways that lower the threshold for itch perception.
Pregnancy also tilts the immune system toward what immunologists call a type 2 response, a shift that helps the body tolerate the genetically foreign fetus. A side effect of that shift is a greater susceptibility to allergic and atopic conditions, which is why some women develop eczema for the first time during pregnancy or see existing eczema flare.2PubMed Central. The management of severe eczema in pregnancy In a study tracking pregnant women, itching began on average around the 27th week and correlated with reduced quality of life, meaning it was not just a cosmetic complaint.3Dermatology Research and Practice. Prevalence and Relevance of Pruritus in Pregnancy
When Itching Could Mean Cholestasis
The itch that worries obstetricians is the one that comes without a rash, intensifies at night, and concentrates on the palms of the hands and soles of the feet. That pattern is the hallmark of intrahepatic cholestasis of pregnancy (ICP), a condition where bile acids build up in the bloodstream because the liver’s ability to export bile is compromised. ICP typically appears in the late second or third trimester. Its overall prevalence varies by population, ranging from under one percent in most European countries to several percent in certain South American and Scandinavian populations, partly because of genetic susceptibility.
Genetic studies have pinpointed several genes involved in bile transport that predispose women to ICP. A large genome-wide association study identified signals at three key gene regions, all of which code for proteins that move bile salts, cholesterol, and related compounds out of liver cells.4Nature Communications. GWAS meta-analysis of intrahepatic cholestasis of pregnancy implicates multiple hepatic genes and regulatory elements Smaller studies have confirmed that mutations in specific bile-transporter genes occur in a meaningful fraction of ICP patients.5PubMed. The role of genetic mutations in intrahepatic cholestasis of pregnancy In practical terms, if your mother or sister had ICP, your own risk is higher.
Recent research has also uncovered a specific biochemical pathway behind the itch itself. An enzyme called autotaxin circulates at higher levels in women with ICP and converts a common blood lipid into lysophosphatidic acid (LPA), a compound that directly activates itch-sensing nerve fibers in the skin. In women with ICP, autotaxin levels are more than double those of healthy pregnant controls, and the enzyme’s activity tracks closely with how severe the itching feels.6PubMed. Serum autotaxin levels correlate with the severity of pruritus in intrahepatic cholestasis of pregnancy 7PubMed Central. The role of autotaxin in pruritus and preterm labor in early-onset intrahepatic cholestasis of pregnancy This connection suggests that autotaxin could become a diagnostic marker or even a drug target down the road.8Annals of Hepatology. Lysophosphatidic acid and atotaxin in patients with cholestasis and pruritus
How Cholestasis Affects the Baby
For the mother, ICP is uncomfortable but not dangerous in a lasting way; the itching and abnormal liver tests resolve after delivery. The concern is fetal. Elevated maternal bile acids cross the placenta and can cause problems for the baby, including premature birth, meconium-stained amniotic fluid (a sign of fetal distress), and in severe cases, stillbirth. A large study found that with each additional unit of bile acid in the mother’s blood, the odds of spontaneous preterm birth and meconium staining rose by about 15 percent, and the odds of perinatal death rose by about 26 percent.9PubMed. Intrahepatic cholestasis of pregnancy: maternal and fetal outcomes associated with elevated bile acid levels
The relationship between bile acid levels and fetal risk is not linear across the whole range, though. Research has consistently shown that fetal complications cluster in women whose bile acid levels reach 40 micromoles per liter or above, a threshold that separates mild ICP from a severe form affecting roughly one in five ICP cases.10PubMed. Intrahepatic cholestasis of pregnancy: Relationships between bile acid levels and fetal complication rates Women with bile acids below that cutoff had no detectable increase in fetal risk in that study, which has practical implications for how aggressively the pregnancy is managed. When bile acids do cross into the severe range, the risk of complications like meconium staining and adverse neonatal outcomes rises sharply.11PubMed. Perinatal outcomes associated with intrahepatic cholestasis of pregnancy
One mechanism behind the worst outcomes is that bile acids, particularly a type called taurocholate that accumulates in the fetal compartment, can disrupt the rhythm of fetal heart cells, leading to arrhythmias.12PubMed. Heart and bile acids – Clinical consequences of altered bile acid metabolism 13Digestive Diseases. Bile Acid Signaling in Fetal Tissues: Implications for Intrahepatic Cholestasis of Pregnancy This is why delivery timing becomes a critical decision. Current practice leans toward delivering ICP pregnancies somewhat early, with the exact timing depending on bile acid severity, to reduce the window of fetal exposure.14PubMed Central. Intrahepatic Cholestasis of Pregnancy: Diagnosis, Management, and Future Directions
Diagnosing ICP
The diagnosis starts with the clinical picture: generalized itching, worse at night, focused on the palms and soles, without a primary rash. Blood tests confirm it. The key lab value is total serum bile acids, which are elevated in ICP. Liver enzymes are often elevated too, but bile acids are the more specific marker and the one used to stratify risk. Because conditions like preeclampsia, hepatitis, and gallbladder disease can also raise liver enzymes during pregnancy, the bile acid test helps distinguish ICP from its mimics.
Distinguishing ICP from other pregnancy skin conditions can be tricky when both a rash and itching are present. For certain conditions, like pemphigoid gestationis, specific lab tests and skin biopsy can confirm the diagnosis. For others, the diagnosis is made purely on clinical appearance.15PubMed. Pregnancy dermatoses: diagnosis, management, and controversies An algorithmic approach, starting with whether the itch comes with a visible rash and where the rash is distributed, helps clinicians sort through the possibilities efficiently.16PubMed. Skin disease in pregnancy: The approach of the obstetric medicine physician
Treatment for Cholestasis
The standard medication for ICP is ursodeoxycholic acid (UDCA), a synthetic bile acid that improves bile flow and lowers circulating bile acid levels. A meta-analysis pooling data from multiple trials found that UDCA was associated with resolution of itching and significant reductions in both bile acid and liver enzyme levels compared with placebo or no treatment.17PubMed Central. Evaluating the effectiveness and safety of ursodeoxycholic acid in treatment of intrahepatic cholestasis of pregnancy However, a separate large individual-patient-data meta-analysis tempered the enthusiasm, concluding that while UDCA does reduce itch, the degree of relief may not meet the threshold for what clinicians consider a meaningful clinical benefit.18PubMed Central. Ursodeoxycholic acid in intrahepatic cholestasis of pregnancy: a systematic review and individual participant data meta-analysis In practice, UDCA remains the first-line treatment because there are few alternatives and it does move bile acid numbers in the right direction, but managing expectations about itch relief is important.
Beyond UDCA, no other drug has strong trial evidence behind it for ICP specifically. For the more common, milder forms of pregnancy itch not caused by cholestasis, the evidence base is even thinner. A Cochrane review looking for randomized trials on pharmacological treatments for generalized itching in pregnancy (not caused by systemic disease or a rash) found no trials at all, leaving clinicians without high-quality evidence to guide prescribing for this common complaint.19PubMed Central. Pharmacological interventions for generalised itching (not caused by systemic disease or skin lesions) in pregnancy
Other Pregnancy Skin Conditions That Itch
ICP gets the most clinical attention because of its fetal risks, but several other itchy skin conditions are specific to pregnancy. Each has a different appearance, different timing, and different implications.
The most common itchy rash of pregnancy goes by the acronym PUPPP (pruritic urticarial papules and plaques of pregnancy). It looks like raised, red, hive-like bumps that start in the stretch marks of the abdomen and spread outward to the thighs and buttocks. In a study of PUPPP cases, the abdomen was affected in nearly all women, with stretch marks involved about 90 percent of the time.20Sriwijaya Journal of Obstetrics and Gynecology. Pruritic Urticarial Papules and Plaques of Pregnancy (PUPPP) in Jakarta, Indonesia PUPPP is intensely itchy but harmless to the baby. It typically shows up in the third trimester of a first pregnancy and resolves after delivery.
Atopic eruption of pregnancy is a broader category that includes eczema flares and small, itchy papules. It is the most common pregnancy dermatosis overall, often starting earlier than PUPPP, sometimes in the first or second trimester. As noted earlier, the immune shift toward type 2 responses during pregnancy drives this. It is bothersome but carries no fetal risk.
Pemphigoid gestationis is rare and much more serious. It is an autoimmune blistering disease that appears only in pregnancy, caused by a breakdown of immune tolerance against a specific protein in the skin’s basement membrane.21PubMed. Pemphigoid gestationis: Toward a better understanding of the etiopathogenesis It starts as itchy hives and progresses to tense blisters. Unlike PUPPP and atopic eruption, pemphigoid gestationis has been associated with prematurity and low birth weight, making it one of the few pregnancy rashes that requires close fetal monitoring alongside skin treatment.22Annals of Dermatology. Dermatoses of pregnancy – clues to diagnosis, fetal risk and therapy
Safe Ways to Manage Everyday Pregnancy Itch
For the majority of pregnant women whose itching is mild and not caused by a systemic condition, treatment is about comfort. The first-line approach is non-pharmacological: fragrance-free moisturizers applied liberally, lukewarm rather than hot showers, loose cotton clothing, and cool compresses on particularly itchy areas. These measures sound simple, but consistent moisturizing can make a real difference when the underlying problem is dry, stretched skin.
When moisturizers aren’t enough, topical corticosteroids are the next step. Studies have found no apparent increase in fetal risk from using topical steroids during pregnancy, though using the lowest potency that controls symptoms is still considered prudent since some data hint at growth restriction with the most potent formulations.23PubMed Central. Topical corticosteroid use during pregnancy For widespread itching or conditions where topical treatment isn’t practical, oral antihistamines are an option. First-generation antihistamines like chlorpheniramine and diphenhydramine have the longest safety record in pregnancy and are generally considered safe. Second-generation antihistamines like cetirizine and loratadine have less data behind them, but published studies are reassuring.24PubMed Central. Safety of antihistamines during pregnancy and lactation 25PubMed Central. A review of antihistamines used during pregnancy The sedating effect of first-generation antihistamines can actually be a benefit when itching is disrupting sleep, though drowsiness during the day is the obvious tradeoff.
It is worth emphasizing that none of these treatments have been tested in rigorous randomized trials specifically for generalized pregnancy itch, as the Cochrane review found. Clinicians are essentially extrapolating from general dermatology experience and safety data, not from pregnancy-specific efficacy trials. That does not mean the treatments don’t work; it means the evidence comes from clinical experience rather than controlled experiments.
Sleep, Mood, and When Itching Takes a Real Toll
Itching during pregnancy gets dismissed easily. It’s invisible, subjective, and doesn’t photograph well for a medical chart. But persistent pruritus genuinely degrades daily life. In a study of women at high risk for ICP, the severity of their itching was directly associated with sleep disturbance, fatigue, and mood changes.26PubMed Central. Impact of pruritus in patients at high risk of significant intrahepatic cholestasis of pregnancy The itch-sleep-fatigue-mood cycle can be vicious: nighttime itching interrupts sleep, sleep deprivation worsens fatigue and anxiety, and the stress itself can lower the itch threshold, making the scratching harder to resist.
This psychological burden is one reason to take new-onset itching in pregnancy seriously even before lab results come back. Women who report severe itching deserve more than a “try some lotion” response. Prompt blood testing for bile acids and liver enzymes, combined with symptomatic treatment while waiting for results, can both reassure the majority and catch the minority who need closer monitoring.
Recurrence in Future Pregnancies
Women who have had ICP often want to know whether it will come back if they get pregnant again. The answer, based on the best available data, is that it recurs in a sizable fraction: roughly 44 percent of women who had ICP in one pregnancy experienced it again in a subsequent pregnancy.27PubMed Central. Intrahepatic Cholestasis of Pregnancy Recurrence in a Subsequent Pregnancy The strongest predictor of recurrence was how severe the first episode was. Women whose bile acids had peaked above 40 micromoles per liter in the index pregnancy were significantly more likely to see ICP return. Interestingly, a longer gap between pregnancies was associated with higher recurrence risk, not lower, which is the opposite of what most women would expect.
For the non-cholestatic itchy conditions, recurrence patterns vary. PUPPP overwhelmingly occurs in first pregnancies and rarely comes back. Pemphigoid gestationis, by contrast, tends to recur and can worsen with each successive pregnancy. Atopic eruption of pregnancy can recur but is less predictable. Knowing the recurrence profile of whatever condition caused itching the first time around can help with planning and early monitoring in future pregnancies.
How to Tell Whether Your Itching Needs Attention
Not every itch in pregnancy warrants a trip to the lab. The practical filter most clinicians use is a combination of timing, location, and severity. Mild, diffuse itching over the belly that lines up with visible skin stretching or dryness, especially in the third trimester, is almost certainly benign. Itching that is concentrated on the palms and soles, that worsens at night to the point of waking you up, or that appears without any visible rash should prompt a call to your provider and a bile acid test. The same goes for itching that starts suddenly in the second or third trimester and feels qualitatively different from anything you’ve experienced before.
A visible rash changes the diagnostic direction. If the itching comes with raised red bumps in the stretch marks, the leading candidate is PUPPP. If it comes with eczema-like patches on the arms, legs, or trunk, atopic eruption is likely. If blisters develop, pemphigoid gestationis needs to be ruled out with a skin biopsy and blood work. The absence of a rash, paradoxically, is the pattern most likely to point toward cholestasis and the one most likely to need urgent follow-up.
One common misconception is that itching only matters if bile acid levels are already very high at the first test. Bile acids can fluctuate and may not peak until later in gestation, so a single normal result does not permanently rule out ICP if itching persists or worsens. Most guidelines recommend repeating the test if symptoms continue. Another misconception is that itching in pregnancy is always hormonal and will sort itself out after delivery. While that is technically true for all the pregnancy-specific conditions, the period before delivery is exactly when fetal risk from cholestasis is highest, so “waiting it out” is not a safe default strategy when the itch is severe and rash-free.